WallStSmart

AGCO Corporation (AGCO)vsSBC Medical Group Holdings Incorporated (SBC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

AGCO Corporation generates 6026% more annual revenue ($10.37B vs $169.34M). SBC leads profitability with a 24.1% profit margin vs 7.4%. SBC trades at a lower P/E of 7.5x. AGCO earns a higher WallStSmart Score of 71/100 (B).

AGCO

Strong Buy

71

out of 100

Grade: B

Growth: 6.0Profit: 5.5Value: 7.0Quality: 7.0
Piotroski: 5/9Altman Z: 2.26

SBC

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 8.5Value: 6.7Quality: 8.5
Piotroski: 2/9Altman Z: 3.94

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AGCO4 strengths · Avg: 9.5/10
P/E RatioValuation
10.8x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
441.9%10/10

Earnings expanding 441.9% YoY

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

SBC6 strengths · Avg: 9.8/10
P/E RatioValuation
7.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
41.1%10/10

Strong operational efficiency at 41.1%

Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.9410/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
24.1%9/10

Keeps 24 of every $100 in revenue as profit

Areas to Watch

AGCO3 concerns · Avg: 2.7/10
Profit MarginProfitability
7.4%3/10

7.4% margin — thin

Operating MarginProfitability
3.9%3/10

Operating margin of 3.9%

Free Cash FlowQuality
$-455.00M2/10

Negative free cash flow — burning cash

SBC4 concerns · Avg: 2.5/10
Market CapQuality
$310.60M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-9.0%2/10

Revenue declined 9.0%

EPS GrowthGrowth
-47.1%2/10

Earnings declined 47.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : AGCO

The strongest argument for AGCO centers on P/E Ratio, EPS Growth, Debt/Equity. Revenue growth of 14.3% demonstrates continued momentum. PEG of 1.12 suggests the stock is reasonably priced for its growth.

Bull Case : SBC

The strongest argument for SBC centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 24.1% and operating margin at 41.1%.

Bear Case : AGCO

The primary concerns for AGCO are Profit Margin, Operating Margin, Free Cash Flow.

Bear Case : SBC

The primary concerns for SBC are Market Cap, Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

AGCO profiles as a value stock while SBC is a declining play — different risk/reward profiles.

AGCO carries more volatility with a beta of 1.08 — expect wider price swings.

AGCO is growing revenue faster at 14.3% — sustainability is the question.

SBC generates stronger free cash flow (9M), providing more financial flexibility.

Bottom Line

AGCO scores higher overall (71/100 vs 52/100) and 14.3% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

AGCO Corporation

INDUSTRIALS · FARM & HEAVY CONSTRUCTION MACHINERY · USA

AGCO Corporation manufactures and distributes agricultural equipment and related spare parts worldwide. The company is headquartered in Duluth, Georgia.

Visit Website →

SBC Medical Group Holdings Incorporated

INDUSTRIALS · CONSULTING SERVICES · USA

SBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.

Visit Website →

Want to dig deeper into these stocks?